The proaggregating and potentiating effect of unfractionated and low molecular weight heparin on platelets of the critically ill patients

Mohamad Hossny Abdalla;

Abstract


Heparin has been widely used in the prevention and treatment of

various thromboembolic disorders for many years, and is considered to be a relatively safe drug. However, a small but significant number of patients receiving heparin develop thrombocytopenia and are at risk for associated complications. Recent studies suggest that the frequency of heparin-induced thrombocytopenia (HIT) is approximately three per cent with unfractionated heparin (Chong et al; 1995).

The aim of this work is to evaluate the incidence of HIT in eighty critical patients receiving different types of heparin (LMWH & UFH) and we also studied the presence of heparin PF4 IgG in the serum of these patients and correlate them to the development of thrombocytopenia.

This study was conducted on eigh!;l patients presenting to the Intensive Care Department. Kasr El Aini-Hospital Faculty of Medicine­ Cairo University.

The patients were randomized into one of the following two groups: -


Group I: Fourty patients 23 males and 17 females who received
L.W.M.H. with mean age of 51 ± 15 years.


Group II: Fourty patients 22 males and 18 females who received

U.F.H. with mean age of51.9 ±.12.9 years.


Other data

Title The proaggregating and potentiating effect of unfractionated and low molecular weight heparin on platelets of the critically ill patients
Other Titles قابلية زيادة التجمع وزيادة الفاعلية للهيبارن الغير مجزئ والهيبارين ذو الوزن الجزيئى المنخفض على الصفائح الدموية فى مرضى الحلات الحرجة
Authors Mohamad Hossny Abdalla
Issue Date 2002

Attached Files

File SizeFormat
ر259.pdf1.4 MBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.